|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 501 to 600 out of 751 for Cdk1

0.029s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
UniProt Feature
Begin: 186
Description: Phosphothreonine; by CDK1
Type: modified residue
End: 186
UniProt Feature
Begin: 764
Description: Phosphoserine; by CDK1
Type: modified residue
End: 764
UniProt Feature
Begin: 246
Description: Phosphoserine; by CDK1
Type: modified residue
End: 246
UniProt Feature
Begin: 275
Description: Phosphothreonine; by CDK1
Type: modified residue
End: 275
UniProt Feature
Begin: 2085
Description: Phosphothreonine; by CDK1
Type: modified residue
End: 2085
UniProt Feature
Begin: 1997
Description: Phosphothreonine; by CDK1
Type: modified residue
End: 1997
UniProt Feature
Begin: 2069
Description: Phosphoserine; by CDK1
Type: modified residue
End: 2069
UniProt Feature
Begin: 2516
Description: Phosphothreonine; by CDK1
Type: modified residue
End: 2516
UniProt Feature
Begin: 537
Description: Phosphoserine; by CDK1
Type: modified residue
End: 537
UniProt Feature
Begin: 470
Description: Phosphothreonine; by CDK1
Type: modified residue
End: 470
UniProt Feature
Begin: 728
Description: Phosphoserine; by CDK1
Type: modified residue
End: 728
UniProt Feature
Begin: 608
Description: Phosphothreonine; by CDK1
Type: modified residue
End: 608
UniProt Feature
Begin: 172
Description: Phosphoserine; by CDK1
Type: modified residue
End: 172
UniProt Feature
Begin: 172
Description: Phosphoserine; by CDK1
Type: modified residue
End: 172
UniProt Feature
Begin: 382
Description: Phosphoserine; by CDK1
Type: modified residue
End: 382
UniProt Feature
Begin: 29
Description: Phosphoserine; by CDK1
Type: modified residue
End: 29
UniProt Feature
Begin: 1380
Description: Phosphothreonine; by CDK1
Type: modified residue
End: 1380
UniProt Feature
Begin: 1375
Description: Phosphothreonine; by CDK1
Type: modified residue
End: 1375
UniProt Feature
Begin: 172
Description: Phosphoserine; by CDK1
Type: modified residue
End: 172
UniProt Feature
Begin: 172
Description: Phosphoserine; by CDK1
Type: modified residue
End: 172
UniProt Feature
Begin: 172
Description: Phosphoserine; by CDK1
Type: modified residue
End: 172
UniProt Feature
Begin: 278
Description: Phosphothreonine; by CDK1
Type: modified residue
End: 278
UniProt Feature
Begin: 274
Description: Phosphoserine; by CDK1
Type: modified residue
End: 274
UniProt Feature
Begin: 71
Description: Phosphoserine; by CDK1
Type: modified residue
End: 71
UniProt Feature
Begin: 62
Description: Phosphothreonine; by CDK1
Type: modified residue
End: 62
UniProt Feature
Begin: 172
Description: Phosphoserine; by CDK1
Type: modified residue
End: 172
UniProt Feature
Begin: 261
Description: Phosphoserine; by CDK1
Type: modified residue
End: 261
UniProt Feature
Begin: 257
Description: Phosphoserine; by CDK1
Type: modified residue
End: 257
UniProt Feature
Begin: 265
Description: Phosphoserine; by CDK1
Type: modified residue
End: 265
UniProt Feature
Begin: 639
Description: Phosphoserine; by CDK1
Type: modified residue
End: 639
UniProt Feature
Begin: 123
Description: Phosphoserine; by CDK1
Type: modified residue
End: 123
UniProt Feature
Begin: 172
Description: Phosphoserine; by CDK1
Type: modified residue
End: 172
UniProt Feature
Begin: 172
Description: Phosphoserine; by CDK1
Type: modified residue
End: 172
UniProt Feature
Begin: 265
Description: Phosphoserine; by CDK1
Type: modified residue
End: 265
UniProt Feature
Begin: 4546
Description: Phosphothreonine; by CDK1
Type: modified residue
End: 4546
UniProt Feature
Begin: 33
Description: Phosphoserine; by CDK1
Type: modified residue
End: 33
UniProt Feature
Begin: 84
Description: Phosphoserine; by CDK1
Type: modified residue
End: 84
UniProt Feature
Begin: 473
Description: Phosphoserine; by CDK1
Type: modified residue
End: 473
UniProt Feature
Begin: 242
Description: Phosphoserine; by CDK1
Type: modified residue
End: 242
Publication
First Author: Nishiyama T
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Aurora B and Cdk1 mediate Wapl activation and release of acetylated cohesin from chromosomes by phosphorylating Sororin.
Volume: 110
Issue: 33
Pages: 13404-9
UniProt Feature
Begin: 3214
Description: Phosphoserine; by CDK1 and CDK2
Type: modified residue
End: 3214
UniProt Feature
Begin: 34
Description: Phosphothreonine; by CDK1 and CDK15
Type: modified residue
End: 34
UniProt Feature
Begin: 164
Description: Phosphoserine; by CDK1 and CDK2
Type: modified residue
End: 164
UniProt Feature
Begin: 291
Description: Phosphoserine; by CDK1 and PKB
Type: modified residue
End: 291
UniProt Feature
Begin: 345
Description: Phosphothreonine; by CDK1 and CDK2
Type: modified residue
End: 345
UniProt Feature
Begin: 90
Description: Phosphoserine; by CDK1 and CDK9
Type: modified residue
End: 90
UniProt Feature
Begin: 198
Description: Phosphothreonine; by CDK1 and CDK2
Type: modified residue
End: 198
UniProt Feature
Begin: 463
Description: Phosphothreonine; by CDK1 and CDK2
Type: modified residue
End: 463
UniProt Feature
Begin: 358
Description: Phosphoserine; by MAPK13 and CDK1
Type: modified residue
End: 358
UniProt Feature
Begin: 528
Description: Phosphoserine; by CDK1 and CDK2
Type: modified residue
End: 528
UniProt Feature
Begin: 245
Description: Phosphothreonine; by CDK1 and MAPK1
Type: modified residue
End: 245
Interaction Experiment
Description: Filamin a regulates neural progenitor proliferation and cortical size through Wee1-dependent Cdk1 phosphorylation.
UniProt Feature
Begin: 187
Description: Phosphothreonine; by PKB/AKT1, CDK1 and CDK2
Type: modified residue
End: 187
UniProt Feature
Begin: 312
Description: Phosphoserine; by AURKA, CDK1 and CDK2
Type: modified residue
End: 312
UniProt Feature
Begin: 645
Description: Phosphoserine; by CDK5, MAPK1 and CDK1
Type: modified residue
End: 645
Publication  
First Author: Zhong L
Year: 2020
Journal: Cell Discov
Title: Phosphorylation of cGAS by CDK1 impairs self-DNA sensing in mitosis.
Volume: 6
Pages: 26
Publication
First Author: Peng Y
Year: 2008
Journal: Dev Cell
Title: The cyclin-dependent kinase Cdk1 directly regulates vacuole inheritance.
Volume: 15
Issue: 3
Pages: 478-85
Protein
Organism: Mus musculus/domesticus
Length: 297  
Fragment?: false
Publication
First Author: Satyanarayana A
Year: 2008
Journal: Mol Biol Cell
Title: p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint.
Volume: 19
Issue: 1
Pages: 65-77
Publication
First Author: Seldin L
Year: 2013
Journal: Mol Biol Cell
Title: NuMA localization, stability, and function in spindle orientation involve 4.1 and Cdk1 interactions.
Volume: 24
Issue: 23
Pages: 3651-62
Publication
First Author: Chou HY
Year: 2011
Journal: Cell Cycle
Title: Phosphorylation of NuSAP by Cdk1 regulates its interaction with microtubules in mitosis.
Volume: 10
Issue: 23
Pages: 4083-9
Publication
First Author: Althoff F
Year: 2009
Journal: Dev Biol
Title: Drosophila Cyclin J is a mitotically stable Cdk1 partner without essential functions.
Volume: 333
Issue: 2
Pages: 263-72
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
Publication
First Author: Löffler H
Year: 2011
Journal: Cancer Res
Title: Cep63 recruits Cdk1 to the centrosome: implications for regulation of mitotic entry, centrosome amplification, and genome maintenance.
Volume: 71
Issue: 6
Pages: 2129-39
Allele  
Name: eukaryotic translation initiation factor 4E binding protein 1; targeted mutation 2.1, Patrick Moore
Allele Type: Targeted
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Protein
Organism: Mus musculus/domesticus
Length: 234  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 233  
Fragment?: false
Publication
First Author: Grundt K
Year: 2004
Journal: Biochem Biophys Res Commun
Title: Characterisation of the NUCKS gene on human chromosome 1q32.1 and the presence of a homologous gene in different species.
Volume: 323
Issue: 3
Pages: 796-801
Protein Domain
Type: Family
Description: Members of this vertebrate family of proteins are targets for phosphorylation by CDK1 and casein kinase [, ]. They are also phosphorylated upon DNA damage, probably by ATM or ATR [].
Publication  
First Author: He Y
Year: 2015
Journal: Biomed Pharmacother
Title: The tumor-suppressor gene LZTS1 suppresses hepatocellular carcinoma proliferation by impairing PI3K/Akt pathway.
Volume: 76
Pages: 141-6
Publication
First Author: Wang XX
Year: 2015
Journal: Pathol Oncol Res
Title: Loss of Leucine Zipper Putative Tumor Suppressor 1 (LZTS1) Expression Contributes to Lymph Node Metastasis of Breast Invasive Micropapillary Carcinoma.
Volume: 21
Issue: 4
Pages: 1021-6
Publication
First Author: Xu Z
Year: 2014
Journal: Biochem Biophys Res Commun
Title: miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.
Volume: 449
Issue: 2
Pages: 190-5
Protein Domain
Type: Family
Description: Leucine zipper putative tumor suppressor 1 (LZTS1, FEZ1) plays a role in mitosis []. It is associated with assembled microtubules and is involved in the stabilization of active p34CDC2 (Cdk1) []. LZTS1 plays an important role in ensuring proper Cdk1 activity during M phase. By maintaining high levels of Cdk1 activity, it prevents chromosomes missegregation []. LZTS1 plays an important role in human carcinogenesis [, , ].
Publication
First Author: Shimada M
Year: 2008
Journal: Cell
Title: Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression.
Volume: 132
Issue: 2
Pages: 221-32
Publication
First Author: Hu J
Year: 2014
Journal: Hum Mol Genet
Title: Formin 1 and filamin B physically interact to coordinate chondrocyte proliferation and differentiation in the growth plate.
Volume: 23
Issue: 17
Pages: 4663-73
Protein Domain
Type: Family
Description: Filamin family consists of Filamin-A (FLN-A), Filamin-B (FLN-B) and Filamin-C (FLN-C). They are a group of actin binding proteins that may be involved in actin microfilaments organisation [].This entry represents filamin B, which transduces signals from various membrane receptors and intracellular proteins onto the actin cytoskeleton []. In humans it regulates chondrocyte proliferation and differentiation through Cdk1 signalling [].
Publication
First Author: Porter LA
Year: 2003
Journal: Mol Biol Cell
Title: Spy1 interacts with p27Kip1 to allow G1/S progression.
Volume: 14
Issue: 9
Pages: 3664-74
Protein
Organism: Mus musculus/domesticus
Length: 310  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 268  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 173  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 236  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 172  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 115  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 309  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 173  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 231  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 339  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 283  
Fragment?: false
Publication
First Author: McAndrew CW
Year: 2007
Journal: Cell Cycle
Title: Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27.
Volume: 6
Issue: 15
Pages: 1937-45
Publication
First Author: McGrath DA
Year: 2017
Journal: EMBO J
Title: Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.
Volume: 36
Issue: 15
Pages: 2251-2262
Publication
First Author: Byeon IJ
Year: 2005
Journal: Nat Struct Mol Biol
Title: Sequential phosphorylation and multisite interactions characterize specific target recognition by the FHA domain of Ki67.
Volume: 12
Issue: 11
Pages: 987-93
Protein Domain
Type: Family
Description: Speedy (Spy1, also known as RINGO A) is a cell cycle regulatory protein which binds and activates CDK1 and CDK2 [], protein kinases that allows progression through G1/S phase and further replication events. Spy1 activates CDK2 inducing a conformational change of the CDK2 T-loop that avoids its phosphorylation []. Spy1 expression overcomes a p27-induced cell cycle arrest to allow for DNA synthesis, so cell cycle progression occurs due to an interaction between Spy1 and p27 [].
Protein Domain
Type: Domain
Description: This entry represents eukaryotic proteins that contain a domain of approximately 40 amino acids in length. These proteins are found in association with . There are two conserved sequence motifs: TPVCTP and LERRKS. This domain is found on the human nucleolar protein hNIFK. It binds to the fork-head-associated domain of human Ki67. High-affinity binding requires sequential phosphorylation by two kinases, CDK1 and GSK3, yielding pThr238, pThr234 and pSer230. This interaction is involved in cell cycle regulation [].
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
Protein
Organism: Mus musculus/domesticus
Length: 599  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 598  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 599  
Fragment?: false
Publication
First Author: Ishii H
Year: 2001
Journal: Proc Natl Acad Sci U S A
Title: FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis.
Volume: 98
Issue: 18
Pages: 10374-9
Publication  
First Author: Vecchione A
Year: 2007
Journal: Cell Div
Title: Fez1/Lzts1 a new mitotic regulator implicated in cancer development.
Volume: 2
Pages: 24